Follistatin-like 1/FSTL1 Antibody (228210) [PE]
Novus Biologicals, part of Bio-Techne | Catalog # FAB1738P
Conjugate
Catalog #
Key Product Details
Species Reactivity
Mouse
Applications
Western Blot
Label
PE (Excitation = 488 nm, Emission = 575 nm)
Antibody Source
Monoclonal Rat IgG2A Clone # 228210
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant mouse Follistatin-like 1/FSTL1
Glu19-Ile306
Accession # Q62356
Glu19-Ile306
Accession # Q62356
Specificity
Detects mouse Follistatin-like 1/FSTL1 in direct ELISAs and Western blots. In direct ELISAs and Western blots, 100% cross-reactivity with recombinant human Follistatin-like 1/FSTL1 is observed.
Clonality
Monoclonal
Host
Rat
Isotype
IgG2A
Applications for Follistatin-like 1/FSTL1 Antibody (228210) [PE]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Follistatin-like 1/FSTL1
Alternate Names
Flik, Follistatin-related Protein, FRP, FSL1, FSTL1, TSC-36
Gene Symbol
FSTL1
Additional Follistatin-like 1/FSTL1 Products
Product Documents for Follistatin-like 1/FSTL1 Antibody (228210) [PE]
Product Specific Notices for Follistatin-like 1/FSTL1 Antibody (228210) [PE]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...